InvestorsHub Logo
Followers 16
Posts 4650
Boards Moderated 0
Alias Born 08/11/2015

Re: None

Monday, 08/14/2017 11:44:04 PM

Monday, August 14, 2017 11:44:04 PM

Post# of 18220

At June 30, 2017, the Company’s equity interest had been further reduced to 12.8%, by subsequent issuances of Cytocom common stock to shareholders in settlement of notes payable.



That's not that bad at all for the past 3 months in my opinion. It was 13.3% on March 31, 2017.